-+ 0.00%
-+ 0.00%
-+ 0.00%

Phathom Q1 net loss narrows to $30.4 million; revenue more than doubles to $58.3 million

PUBT·04/30/2026 10:59:41
Listen to the news
Phathom Q1 net loss narrows to $30.4 million; revenue more than doubles to $58.3 million
  • Phathom Pharmaceuticals posted Q1 net loss of $30.4 million, narrowing from year-ago loss of $94.3 million.
  • Revenue jumped 104% to $58.3 million.
  • Operating loss tightened to $15.5 million from $78.9 million.
  • VOQUEZNA prescriptions filled rose 115% to 268,000, with 63% of Q1 volume covered by insurance.
  • Full-year 2026 guidance maintained for revenue of $320-$345 million, with operating profitability expected starting in Q3 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Phathom Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202604300659PRIMZONEFULLFEED9710158) on April 30, 2026, and is solely responsible for the information contained therein.